Sustainability Report

Overview

The report describes Sun Pharma's FY23 sustainability performance across environmental, workforce and social-value programmes. It reports that 32% of energy came from renewable sources and sets a 35% absolute Scope 1 and Scope 2 emissions reduction target by 2030. The company also revised its materiality process using double materiality principles and disclosed extensive GRI-indexed ESG information. DNV Business Assurance India provided limited assurance over the sustainability disclosures.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 April 2022 – 31 March 2023
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services